| # | Drug | Count |
|---|---|---|
| 0 | RANITIDINE | 31 |
| 1 | EVEROLIMUS | 25 |
| 2 | CAPECITABINE | 24 |
| 3 | FULVESTRANT | 24 |
| 4 | FENTANYL | 23 |
| 5 | MEFENAMIC ACID | 22 |
| 6 | PAMIDRONATE DISODIUM | 20 |
| 7 | FINGOLIMOD HCL | 17 |
| 8 | ACETAMINOPHEN | 11 |
| 9 | METHYLPREDNISOLONE | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MEFENAMIC ACID | 22 | 0.0099 |
| 1 | PAMIDRONATE DISODIUM | 20 | 0.0059 |
| 2 | ODEVIXIBAT | 2 | 0.0050 |
| 3 | TOREMIFENE CITRATE | 1 | 0.0023 |
| 4 | CEFACLOR | 2 | 0.0013 |
| 5 | CEFPROZIL | 1 | 0.0013 |
| 6 | FLUVOXAMINE MALEATE | 3 | 0.0012 |
| 7 | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | 1 | 0.0009 |
| 8 | FULVESTRANT | 24 | 0.0007 |
| 9 | NIZATIDINE | 1 | 0.0007 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 37 |
| 1 | Kinase Inhibitor [EPC] | 32 |
| 2 | Opioid Agonist [EPC] | 25 |
| 3 | mTOR Inhibitor Immunosuppressant [EPC] | 25 |
| 4 | Estrogen Receptor Antagonist [EPC] | 24 |
| 5 | Nucleoside Metabolic Inhibitor [EPC] | 24 |
| 6 | Corticosteroid [EPC] | 20 |
| 7 | Proton Pump Inhibitor [EPC] | 11 |
| 8 | Benzodiazepine [EPC] | 10 |
| 9 | Atypical Antipsychotic [EPC] | 9 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Ileal Bile Acid Transporter Inhibitor [EPC] | 2 | 0.0044 |
| 1 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 2 | Estrogen Receptor Antagonist [EPC] | 24 | 0.0006 |
| 3 | CD52-directed Cytolytic Antibody [EPC] | 8 | 0.0004 |
| 4 | Provitamin D2 Compound [EPC] | 6 | 0.0002 |
| 5 | Catechol-O-Methyltransferase Inhibitor [EPC] | 1 | 0.0002 |
| 6 | Bile Acid [EPC] | 4 | 0.0002 |
| 7 | Bile Acid Sequestrant [EPC] | 2 | 0.0002 |
| 8 | Cephalosporin Antibacterial [EPC] | 1 | 0.0001 |
| 9 | Rifamycin Antibacterial [EPC] | 4 | 0.0001 |